ReviewObesity reviews : an official journal of the International Association for the Study of Obesity2026
Inflammatory Bowel Disease in Children and Young People Living With Overweight or Obesity: A Critical Narrative Review.
Review in Obesity reviews : an official journal of the International Association for the Study of Obesity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inflammatory bowel disease is a chronic inflammatory disorder affecting the gastrointestinal tract. It mainly comprises of Crohn's disease and ulcerative colitis. Its global prevalence has risen simultaneously with overweight and obesity among children and young people over the last decades. This critical narrative review aims to explore how living with overweight or obesity contributes to the development of inflammatory bowel disease (IBD) as well as the disease course in children and young people. Approximately, 24% of children and young people with the disease are living with overweight or obesity, with the majority being diagnosed with ulcerative colitis. Obesity appears to be associated with increased disease activity, adverse effects, with increased adiposity contributing to IBD pathogenesis though multiple mechanisms. Here, we offer a novel mechanistic pathway to how obesity impacts on IBD pathogenesis. Increased adiposity appears to contribute to its pathogenesis through increased proinflammatory cytokines and microbiota imbalance leading to inflammation and increased intestinal permeability. Additionally, adiposity appears to exacerbate micronutrient deficiencies associated with inflammatory bowel disease, including iron and vitamin D. Obesity is also shown to be associated with increased disease activity. Finally, we review possible weight management interventions available to children and young people living with obesity and overweight and IBD. In conclusion, living with overweight and obesity are proposed to have adverse effects on inflammatory bowel disease in children and young people, with an urgent need for greater research to better understand their impacts and assist in guiding effective tailored interventions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.